Sarepta Therapeutics Inc (SRPT), PTC Therapeutics, Inc. (PTCT) and More: Here’s Why These Stocks Are on Investors’ Radars Today

Vical Incorporated (NASDAQ:VICL) is over 24% in the red after data from a Phase 2 clinical trial assessing ASP0113 showed that the vaccine failed to achieve its primary endpoint. ASP0113 is Vical’s investigational Cytomegalovirus vaccine for patients with kidney transplants. Just four funds tracked by us had a bullish position in Vical Incorporated (NASDAQ:VICL) at the end of the second quarter, unchanged from the previous quarter.

CVR Refining LP (NYSE:CVRR) is in the spotlight today after the company entered into definitive agreements with Velocity Midstream Partners, LLC to form a joint venture, that will connect the fairway of the South Central Oklahoma Oil Province to CVR Refining’s Wynnewood refinery with a crude oil pipeline and terminal. CVR Refining will hold a 40% stake in the venture. At the end of June, seven investors from our database were long CVR Refining LP (NYSE:CVRR) at the end of June.

WebMD Health Corp. (NASDAQ:WBMD) is in the news after the company’s board appointed Steven L. Zatz, M.D. to be the company’s CEO effective immediately. Dr. Zatz was previously the company’s President and will replace the former CEO David J. Schlanger, who is leaving by mutual agreement. Although the company’s board has also increased the stock buyback authorization by $35 million to $50 million, traders didn’t like the abrupt management change and WebMD shares are off by 6.8% as a result. The number of funds tracked by us with holdings in WebMD Health Corp. (NASDAQ:WBMD) rose by one quarter-over-quarter to 27 at the end of the last quarter.

Disclosure: none